UMB Bank’s Axsome Therapeutics AXSM Stock Holding History

UMB Bank’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21K	Hold	124	–	–	﹤0.01%	1586
2025 Q4	$22.6K	Sell	124 -247	-67%	-$34.5K	﹤0.01%	1518
2025 Q3	$45.1K	Buy	371 +253	+214%	+$28.5K	﹤0.01%	1197
2025 Q2	$12.3K	Hold	118	–	–	﹤0.01%	1530
2025 Q1	$13.8K	Hold	118	–	–	﹤0.01%	1436
2024 Q4	$9.98K	Sell	118 -13	-10%	-$1.2K	﹤0.01%	1473
2024 Q3	$11.8K	Sell	131 -3	-2%	-$262	﹤0.01%	1421
2024 Q2	$10.8K	Sell	134 -11	-8%	-$814	﹤0.01%	1251
2024 Q1	$11.6K	Sell	145 -18	-11%	-$1.51K	﹤0.01%	1246
2023 Q4	$13K	Hold	163	–	–	﹤0.01%	1201
2023 Q3	$11.4K	Hold	163	–	–	﹤0.01%	1256
2023 Q2	$11.7K	Hold	163	–	–	﹤0.01%	1259
2023 Q1	$10.1K	Sell	163 -4	-2%	-$263	﹤0.01%	1291
2022 Q4	$13K	Hold	167	–	–	﹤0.01%	1211
2022 Q3	$7K	Buy	+167	New	+$8.35K	﹤0.01%	1393
2022 Q1	–	Sell	-370	Closed	-$14K	–	1973
2021 Q4	$14K	Buy	+370	New	+$13.6K	﹤0.01%	1356

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UMB Bank's AXSM Position: Q1 2026 in Review

UMB Bank held its Axsome Therapeutics (AXSM) position steady in Q1 2026 at 124 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #1586.

UMB Bank first reported a position in AXSM in Q4 2021 and has held it in 16 quarters since. The position peaked at $45.1K in Q3 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

UMB Bank held 124 shares of Axsome Therapeutics worth $21K as of Q1 2026.
UMB Bank left its Axsome Therapeutics share count unchanged in Q1 2026.
Axsome Therapeutics made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #1586 holding.
UMB Bank first reported a position in Axsome Therapeutics in Q4 2021 and has held it in 16 quarters since.
UMB Bank's Axsome Therapeutics position peaked at $45.1K in Q3 2025.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.